Elevated plasma von Willebrand factor and propeptide levels in Malawian children with malaria

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Phiri, Happy T ^a   Bridges, Daniel J ^a   Glover, Simon J ^a   van Mourik, Jan A ^b   de Laat, Bas ^b   M'baya, Bridon ^c   Taylor, Terrie E ^a,d   Seydel, Karl B ^a,d   Molyneux, Malcolm E ^a,e   Faragher, E Brian ^e   Craig, Alister G ^e   Bunn, James E G ^a,e  

^a UNIVERSITY OF MALAWI   (Malawi)

^b Departments of Plasma Proteins and Blood Coagulation   (Netherlands)

^c Malawi Blood Transfusion Service   (Malawi)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR PROPEPTIDE; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; BRAIN MALARIA; CHILD; COMATOSE PATIENT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALAWI; MALE; OPHTHALMOSCOPY; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RETINOPATHY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; ADULT; BLOOD; DIFFERENTIAL DIAGNOSIS; MALARIA; RETINA DISEASE;

PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMANS; INFANT; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALAWI; MALE; OPHTHALMOSCOPY; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RETINAL DISEASES; SENSITIVITY AND SPECIFICITY; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 81255128904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025626     Document Type: Article

References (34)

1. Newton CR, Taylor TE, Whitten RO, (1998) Pathophysiology of fatal falciparum malaria in African children. Am J Trop Med Hyg 58: 673-83.
2. Ettling M, Steketee RW, Macheso A, Schultz LJ, Nyasulu Y, et al. (1994) Malaria knowledge, attitudes and practices in Malawi: survey population characteristics. Trop Med Parasitol 45: 57-60.
3. Sulo J, Chimpeni P, Hatcher J, Kublin JG, Plowe CV, et al. (2002) Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet 360: 1136-43.
4. van Mourik JA, Romani de Wit T, (2001) Von Willebrand factor propeptide in vascular disorders. Thromb Haemost 86: 164-71.
5. Rubin DB, Wiener-Kronish JP, Murray JF, Green DR, Turner J, et al. (1990) Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 86: 474-80.
6. Zeigler ZR, Rosenfeld CS, Andrews DF 3rd, Nemunaitis J, Raymond JM, et al. (1996) Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol 53: 213-20.
7. Stel HV, Sakariassen KS, de Groot PG, van Mourik JA, Sixma JJ, (1985) Von Willebrand factor in the vessel wall mediates platelet adherence. Blood 65: 85-90.
8. Ruggeri ZM, Ware J, (1993) von Willebrand factor. FASEB J 7: 308-16.
9. Wagner DD, Fay PJ, Sporn LA, Sinha S, Lawrence SO, et al. (1987) Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells. Proc Natl Acad Sci U S A 84: 1955-9.
10. Hannah MJ, Skehel P, Erent M, Knipe L, Ogden D, et al. (2005) Differential kinetics of cell surface loss of von Willebrand factor and its propolypeptide after secretion from Weibel-Palade bodies in living human endothelial cells. J Biol Chem 280: 22827-30.
11. Wise RJ, Pittman DD, Handin RI, Kaufman RJ, Orkin SH, (1988) The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52: 229-36.
12. Rosenberg JB, Haberichter SL, Jozwiak MA, Vokac EA, Kroner PA, et al. (2002) The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF. Blood 100: 1699-706.
13. Mayadas TN, Wagner DD, (1991) von Willebrand factor biosynthesis and processing. Ann N Y Acad Sci 614: 153-66.
14. van Mourik JA, Boertjes R, Huisveld IA, Fijnvandraat K, Pajkrt D, et al. (1999) von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation. Blood 94: 179-85.
15. Hollestelle MJ, Donkor C, Mantey EA, Chakravorty SJ, Craig A, et al. (2006) von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. Br J Haematol 133: 562-9.
16. de Mast Q, Groot E, Lenting PJ, de Groot PG, McCall M, et al. (2007) Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. J Infect Dis 196: 622-8.
17. Larkin D, de Laat B, Jenkins PV, Bunn J, Craig AG, et al. (2009) Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog 5: e1000349.
18. Bridges DJ, Bunn J, van Mourik JA, Grau G, Preston RJ, et al. (2010) Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood 115: 1472-4.
19. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, et al. (2004) Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 329: 1212.
20. Beare NA, Taylor TE, Harding SP, Lewallen S, Molyneux ME, (2006) Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg 75: 790-7.
21. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A, (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71: 441-59.
22. WHO (2000) Severe falciparum malaria. Trans. R Soc Trop Med Hyg 94: S1-90.
23. Borchiellini A, Fijnvandraat K, ten Cate JW, Pajkrt D, van Deventer SJ, et al. (1996) Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood 88: 2951-8.
24. Vischer UM, Ingerslev J, Wollheim CB, Mestries JC, Tsakiris DA, et al. (1997) Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels. Thromb Haemost 77: 387-93.
25. White NJ, Warrell DA, Looareesuwan S, Chanthavanich P, Phillips RE, et al. (1985) Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. Lancet 1: 776-8.
26. Krishna S, Waller DW, ter Kuile F, Kwiatkowski D, Crawley J, et al. (1994) Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg 88: 67-73.
27. Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JS, et al. (2004) Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 10: 143-5.
28. Conroy AL, Phiri H, Hawkes M, Glover S, Mallewa M, et al. (2010) Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One 5: e15291.
29. Erdman LK, Dhabangi A, Musoke C, Conroy AL, Hawkes M, et al. (2011) Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One 6: e17440.
30. Wassmer SC, Lepolard C, Traore B, Pouvelle B, Gysin J, et al. (2004) Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. J Infect Dis 189: 180-9.
31. Silamut K, Phu NH, Whitty C, Turner GD, Louwrier K, et al. (1999) A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 155: 395-410.
32. Arman M, Raza A, Tempest LJ, Lyke KE, Thera MA, et al. (2007) Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children. Am J Trop Med Hyg 77: 943-6.
33. Sadler JE, (1998) Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67: 395-424.
34. Sadler JE, (2002) Biomedicine. Contact-how platelets touch von Willebrand factor. Science 297: 1128-9.